The Covid vaccine results are great news, but it's not all over yet
by Sarah Boseley Global health editor from on (#5AR37)
Oxford/AstraZeneca findings have certain advantages over those from other versions
Within weeks, the prospects of an end to the pandemic have changed utterly, with three vaccines against Covid-19 reporting good results in final clinical trials and at least one likely to be used before Christmas. But there are still huge challenges ahead.
The results from the Oxford University/AstraZeneca vaccine, which is absolutely central to the UK's vaccination strategy, may at first glance look not as good as those of Pfizer/BioNTech and Moderna - the two mRNA vaccines that have both reported 95% efficacy.
Continue reading...